Makoto Ukai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Makoto Ukai has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Ami Okuda
Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan
3 shared publicationsH. Mitsunaga
2 shared publicationsTakayoshi Mamiya
Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya 468-8503, Japan
2 shared publicationsHui Ping Lin
1 shared publicationM. Suzuki
Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Japan
1 shared publicationT. Mamiya
Department of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Japan
1 shared publication
Latest Publications
- 1 January 2005
- Published by Portico in Methods and Findings in Experimental and Clinical Pharmacology
- Vol. 27 (9) , 645-9
Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat
The present study was carried out to determine the involvement of dopamine receptor subtypes D3 and D4, in the discriminative stimulus effects of cocaine in the rats trained to discriminate 10 mg/kg of cocaine from vehicle. The discriminative stimulus effects of cocaine (1-10 mg/kg) were dose-dependent. The dopamine D2 receptor agonist bromocriptine (1.25-20 mg/kg) and the dopamine D3 receptor agonist R(+)-7-OH-DPAT (0.0001-0.3 mg/kg) produced cocaine (10 mg/kg)-like discriminative stimulus effects. Both the dopamine D3 receptor antagonist GR103691 (1 mg/kg) and the dopamine D4 receptor antagonist L745870 (1 mg/kg) partially antagonized the discriminative stimulus effects of cocaine (10 mg/kg) and the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg). L745870 (0.001 mg/kg) inhibited the antagonistic effects of GR103691 (1 mg/kg) on the discriminative stimulus effects of cocaine (10 mg/kg), whereas the drug (0.001 mg/kg) enhanced the antagonistic effects of GR103691 (1 mg/kg) on the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg). GR103691 (1 mg/kg) in combination with L745870 (0.001 mg/kg) did not markedly affect the cocaine (10 mg/kg)-like discriminative stimulus effects of bromocriptine (20 mg/kg). These results suggest that the discriminative stimulus effects of cocaine are different from the cocaine-like discriminative stimulus effects of bromocriptine or R(+)-7-OH-DPAT, in terms of dopamine D3 and D4 receptors.
- 1 January 2005
- Published by Portico in Methods and Findings in Experimental and Clinical Pharmacology
- Vol. 27 (9) , 645-9
Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat
The present study was carried out to determine the involvement of dopamine receptor subtypes D3 and D4, in the discriminative stimulus effects of cocaine in the rats trained to discriminate 10 mg/kg of cocaine from vehicle. The discriminative stimulus effects of cocaine (1-10 mg/kg) were dose-dependent. The dopamine D2 receptor agonist bromocriptine (1.25-20 mg/kg) and the dopamine D3 receptor agonist R(+)-7-OH-DPAT (0.0001-0.3 mg/kg) produced cocaine (10 mg/kg)-like discriminative stimulus effects. Both the dopamine D3 receptor antagonist GR103691 (1 mg/kg) and the dopamine D4 receptor antagonist L745870 (1 mg/kg) partially antagonized the discriminative stimulus effects of cocaine (10 mg/kg) and the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg). L745870 (0.001 mg/kg) inhibited the antagonistic effects of GR103691 (1 mg/kg) on the discriminative stimulus effects of cocaine (10 mg/kg), whereas the drug (0.001 mg/kg) enhanced the antagonistic effects of GR103691 (1 mg/kg) on the cocaine (10 mg/kg)-like discriminative stimulus effects of R(+)-7-OH-DPAT (0.3 mg/kg). GR103691 (1 mg/kg) in combination with L745870 (0.001 mg/kg) did not markedly affect the cocaine (10 mg/kg)-like discriminative stimulus effects of bromocriptine (20 mg/kg). These results suggest that the discriminative stimulus effects of cocaine are different from the cocaine-like discriminative stimulus effects of bromocriptine or R(+)-7-OH-DPAT, in terms of dopamine D3 and D4 receptors.
- 1 May 2004
- Published by Elsevier in European Journal of Pharmacology
- Vol. 492 (2-3) , 183-187
Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice
- 1 May 2004
- Published by Elsevier in European Journal of Pharmacology
- Vol. 492 (2-3) , 183-187
Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice
- 1 January 2003
- Published by Portico in Methods and Findings in Experimental and Clinical Pharmacology
- Vol. 25 (5) , 355-359
Tail-swing behavior: A novel animal model for anxiety
The present study was designed to examine the effects of diazepam, nitrazepam, desipramine and haloperidol on tail-swing behavior in mice and to characterize the effects of diazepam. Mice were suspended with rubber bands tied around their upper bodies in order to force their heads upwards. The duration of tail-swing behavior was then measured. Diazepam (0.3 and 1 mg/kg) and nitrazepam (0.3 and 1 mg/kg) significantly depressed tail-swing behavior, while they did not affect ambulation or muscle tone. In contrast, desipramine (10-30 mg/kg) did not affect tail-swing behavior, but at doses of 17.5 and 30 mg/kg produced a marked reduction in ambulation. Haloperidol (0.15 mg/kg) significantly decreased both tail-swing behavior and ambulation. The benzodiazepine receptor antagonist flumazenil (1 and 10 mg/kg), the benzodiazepine receptor inverse agonist beta-carboline-3-carboxylic acid N-methylamide (beta-CCM; 3 mg/kg) and the GABA(A) receptor antagonist bicuculline (3 mg/kg) reversed the effects of diazepam (1 mg/kg) on tail-swing behavior, although administered alone they failed to influence such behavior. These results suggest that anxiety and/or fear are responsible for tail-swing behavior.
- 1 January 2003
- Published by Portico in Methods and Findings in Experimental and Clinical Pharmacology
- Vol. 25 (5) , 355-359
Tail-swing behavior: A novel animal model for anxiety
The present study was designed to examine the effects of diazepam, nitrazepam, desipramine and haloperidol on tail-swing behavior in mice and to characterize the effects of diazepam. Mice were suspended with rubber bands tied around their upper bodies in order to force their heads upwards. The duration of tail-swing behavior was then measured. Diazepam (0.3 and 1 mg/kg) and nitrazepam (0.3 and 1 mg/kg) significantly depressed tail-swing behavior, while they did not affect ambulation or muscle tone. In contrast, desipramine (10-30 mg/kg) did not affect tail-swing behavior, but at doses of 17.5 and 30 mg/kg produced a marked reduction in ambulation. Haloperidol (0.15 mg/kg) significantly decreased both tail-swing behavior and ambulation. The benzodiazepine receptor antagonist flumazenil (1 and 10 mg/kg), the benzodiazepine receptor inverse agonist beta-carboline-3-carboxylic acid N-methylamide (beta-CCM; 3 mg/kg) and the GABA(A) receptor antagonist bicuculline (3 mg/kg) reversed the effects of diazepam (1 mg/kg) on tail-swing behavior, although administered alone they failed to influence such behavior. These results suggest that anxiety and/or fear are responsible for tail-swing behavior.
- 1 September 2002
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 109 (9) , 1221-1225
Effects of U-50,488H, a κ-opioid receptor agonist, on the learned helplessness model of depression in mice
We investigated the effects of U-50,488H, a κ-opioid receptor agonist, on the learned helplessness model of depression in mice. Mice pre-exposed to inescapable electric footshock were treated with U-50,488H. Stimulation of the κ-opioid receptor by U-50,488H (10 mg/kg/day, i.p.) attenuated the escape failure induced by pre-exposure to shock. This attenuation by U-50,488H was blocked by MR2266 (10 mg/kg/day, s.c.), an opioid receptor antagonist. These results suggest that the κ-opioid system plays an important role in the learned helplessness depression in mice.
- 1 September 2002
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 109 (9) , 1221-1225
Effects of U-50,488H, a κ-opioid receptor agonist, on the learned helplessness model of depression in mice
We investigated the effects of U-50,488H, a κ-opioid receptor agonist, on the learned helplessness model of depression in mice. Mice pre-exposed to inescapable electric footshock were treated with U-50,488H. Stimulation of the κ-opioid receptor by U-50,488H (10 mg/kg/day, i.p.) attenuated the escape failure induced by pre-exposure to shock. This attenuation by U-50,488H was blocked by MR2266 (10 mg/kg/day, s.c.), an opioid receptor antagonist. These results suggest that the κ-opioid system plays an important role in the learned helplessness depression in mice.
- 1 June 2002
- Published by Elsevier in European Journal of Pharmacology
- Vol. 446 (1-3) , 97-101
Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice
- 1 June 2002
- Published by Elsevier in European Journal of Pharmacology
- Vol. 446 (1-3) , 97-101
Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice